BRISTOL MYERS SQUIBB
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1989-01-01
- Employees
- 30K
- Market Cap
- $97.5B
- Website
- https://www.bms.com/
A Dose-Defining Study of CXL-1020 in Patients With Systolic Heart Failure
- Conditions
- Heart Failure
- Interventions
- First Posted Date
- 2010-03-30
- Last Posted Date
- 2016-11-15
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 69
- Registration Number
- NCT01096043
- Locations
- 🇺🇸
University of Florida, Jacksonville, Florida, United States
🇺🇸Florida Hospital Transplant Center, Orlando, Florida, United States
🇺🇸Henry Ford Health System, Detroit, Michigan, United States
Safety Study of Abatacept in Sweden
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2010-03-29
- Last Posted Date
- 2022-06-16
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 92635
- Registration Number
- NCT01094795
Safety and Hemodynamic Effects and Pharmacokinetics of CXL-1020 in Patients With Stable Heart Failure
- Conditions
- Heart Failure
- Interventions
- Drug: Placebo for CXL-1020 Cohort 1Drug: Placebo for CXL-1020 Cohort 2
- First Posted Date
- 2010-03-24
- Last Posted Date
- 2016-07-01
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 28
- Registration Number
- NCT01092325
- Locations
- 🇺🇸
Orange County Clinical Research Center, Tustin, California, United States
Safety Study of Abatacept to Treat Rheumatoid Arthritis (B)
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2010-03-17
- Last Posted Date
- 2019-01-18
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 20000
- Registration Number
- NCT01088360
Safety Study of Abatacept to Treat Rheumatoid Arthritis (A)
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2010-03-17
- Last Posted Date
- 2016-12-08
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 81332
- Registration Number
- NCT01088321
Abatacept Pregnancy Exposure Registry
- First Posted Date
- 2010-03-16
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 42
- Registration Number
- NCT01087125
- Locations
- 🇺🇸
Bristol-Myers Squibb, Active, Princeton, New Jersey, United States
Safety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal Cancer
- First Posted Date
- 2010-03-15
- Last Posted Date
- 2016-06-27
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 17
- Registration Number
- NCT01086267
- Locations
- 🇺🇸
Oncology Research Associates D/B/A, Scottsdale, Arizona, United States
🇨🇦Local Institution, Ottawa, Ontario, Canada
🇺🇸Usc Norris Comprehensive Cancer Center, Los Angeles, California, United States
Safety Study of BMS-844421 for Treatment of Hypercholesterolemia
- Conditions
- HypercholesterolemiaAtherosclerosis
- Interventions
- Drug: 0.9% sodium chloride injection solution
- First Posted Date
- 2010-03-08
- Last Posted Date
- 2011-01-26
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 40
- Registration Number
- NCT01082562
- Locations
- 🇩🇪
Local Institution, Berlin, Germany
Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2011-02-07
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 32
- Registration Number
- NCT01079819
- Locations
- 🇺🇸
West Coast Clinical Trials, Llc, Cypress, California, United States
🇺🇸California Clinical Trials Medical Group, Glendale, California, United States
🇺🇸Iberica Clinical Research Center, Eatontown, New Jersey, United States
A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection
- Conditions
- Chronic Hepatitis B Virus, Pediatric
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2019-05-09
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 180
- Registration Number
- NCT01079806
- Locations
- 🇺🇸
Children'S National Medical Center, Washington, District of Columbia, United States
🇺🇸Shah, Uzma, Boston, Massachusetts, United States
🇺🇸Children'S Hospital Of Philadelphia, Philadelphia, Pennsylvania, United States